Skip to main content
Search
Search This Blog
GeneCellTherapy
Posts
Showing posts from October, 2023
Show all
October 29, 2023
Penetrating Solid Tumors with CAR Immune Cells
October 27, 2023
Prof. Cyrille Cohen, Enhancing the anti tumor function of TCR/CAR engi...
October 27, 2023
Deciphering CAR-T Cells: Exploring Functional Mechanisms to Drive Next G...
October 27, 2023
High-throughput screening of synthetic costimulatory domains to modulate...
October 26, 2023
Engineering universal chimeric antigen receptors (CARs) for cancer therapy
October 26, 2023
A cGMP Compatible, Non-Viral CAR T Cell Manufacturing Process
October 24, 2023
Mesothelin-specific CAR-T Cell Therapy with HLA-gated Safety Mechanism S...
October 23, 2023
Memory rich CAR T cell engineering by piggyBac transposon system for sol...
October 23, 2023
Recombinant Antibody Production: Current Methods and a Novel Antibody Ge...
October 23, 2023
Development of a T-cell engineering platform for fully individualized ne...
October 23, 2023
Genomic Immunology and Engineering Immunity
October 23, 2023
TRACeR Antigen centric MHC recognition by a novel engineered protein pla...
October 22, 2023
CD3ζ as a novel integration site for reprogramming immune cells with Chi...
October 22, 2023
Parallel CAR T-Cell Immunotherapy of Solid Tumours by John Maher
October 22, 2023
GenScript Webinar - Unlocking the Future of Cell Therapy: Non-Viral Gene...
October 21, 2023
Expression vectors: how to choose, or customize, vectors for gene & protein expression
October 20, 2023
TCR targets validation through T cell activation
October 17, 2023
manufacturing of T Cells with artificial antigen presenting cells
October 17, 2023
Cell culture automation
October 17, 2023
Engineering strategies for improving CART therapy against cancer
October 17, 2023
Using PD1+ as a Selector for Neoantigen-Responsive TILs
October 17, 2023
Enhancing Efficacy through CAR Structure Optimization: A Report by Leucid Bio.
Newer Posts
Home
